Aveanna (AVAH) insider filing shows small internal share distribution
Rhea-AI Filing Summary
Form 4 filing for Aveanna Healthcare Holdings (AVAH) dated 07/10/2025 discloses ownership changes by 10% owner J.H. Whitney Equity Partners VII, LLC and its affiliated funds.
- No shares are now held directly by the reporting person; all ownership is indirect.
- Indirect holdings remain substantial: 28,890,756 shares via J.H. Whitney VII, L.P.; 15,523,809 shares via PSA Healthcare Investment Holdings LLC; and 1,426,034 shares via PSA Iliad Holdings LLC.
- Two transactions coded “J” (other, no consideration) were recorded on 07/10/2025: in-kind distributions of 64,773 shares from PSA Healthcare and 17,109 shares from PSA Iliad Holdings to their respective members at a price of $0.
- The filing states these distributions were purely structural; the reporting entities disclaim beneficial ownership beyond their economic interest.
No derivative securities were involved and no purchase or sale for cash occurred. The overall economic exposure of the reporting group declined by only 81,882 shares (<0.2% of their prior holding), suggesting a minor internal reallocation rather than a traditional insider sale.
Positive
- None.
Negative
- Minor reduction in 10% holder’s stake through in-kind distributions may hint at future ownership diversification, though current impact is negligible.
Insights
TL;DR: Minor in-kind distributions reduce affiliated fund holdings by 0.2%, no cash sale; limited market impact.
The Form 4 shows token share transfers—81,882 shares in total—distributed free of consideration to members of two affiliated LLCs. The reporting person remains a 10%+ holder with more than 45 million shares. Because the transactions are internal and non-monetary, they do not signal a change in investment thesis or near-term liquidity pressure on AVAH shares. Trading volumes and float are effectively unchanged, so I view the disclosure as neutral for valuation.
TL;DR: Internal ownership reshuffle; monitoring of 10% owner’s future moves still warranted.
The filing clarifies the complex control chain among J.H. Whitney entities and records small distributions that slightly lower aggregate ownership. While immaterial today, it underscores that a concentrated shareholder continues to exert significant influence (≈33% of basic shares). Investors should watch subsequent filings for larger disposals that could affect governance balance or share overhang.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Common Stock, $0.01 par value | 64,773 | $0.00 | $0.00 |
| Other | Common Stock, $0.01 par value | 17,109 | $0.00 | $0.00 |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
Footnotes (3)
- F1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F2. In-kind distribution from PSA Healthcare to its members.
- F3. In-kind distribution from PSA Iliad Holdings to its members.
AI-generated analysis. How Rhea-AI works. Not financial advice.
